Table 3.
Blindness |
Moderate and severe vision impairment |
Mild vision impairment |
|||||||
---|---|---|---|---|---|---|---|---|---|
Number, millions | Crude prevalence | Age-standardised prevalence | Number, millions | Crude prevalence | Age-standardised prevalence | Number, millions | Crude prevalence | Age-standardised prevalence | |
All | |||||||||
All ages | 43·28 (37·57–48·36) | 0·55% (0·48–0·61) | 0·52% (0·46–0·59) | 295·09 (267·32–324·60) | 3·74% (3·39–4·12) | 3·58% (3·24–3·92) | 257·83 (232·66–285·34) | 3·27% (2·95–3·62) | 3·20% (2·89–3·54) |
≥50 years | 33·61 (28·58–38·54) | 1·77% (1·51–2·03) | 1·85% (1·57–2·11) | 206·42 (182·37–233·16) | 10·87% (9·61–12·28) | 11·18% (9·90–12·61) | 142·88 (122·12–163·00) | 7·53% (6·43–8·59) | 7·73% (6·62–8·82) |
Men | |||||||||
All ages | 19·40 (16·95–21·70) | 0·49% (0·43–0·55) | 0·50% (0·44–0·56) | 132·12 (119·77–145·68) | 3·34% (3·03–3·68) | 3·37% (3·05–3·70) | 115·54 (104·37–127·95) | 2·92% (2·64–3·23) | 2·97% (2·68–3·28) |
≥50 years | 14·56 (12·38–16·73) | 1·61% (1·37–1·85) | 1·76% (1·49–2·01) | 89·44 (78·70–101·43) | 9·87% (8·68–11·19) | 10·49% (9·30–11·83) | 60·56 (51·60–69·25) | 6·68% (5·69–7·64) | 7·11% (6·07–8·11) |
Women | |||||||||
All ages | 23·88 (20·83–26·82) | 0·61% (0·53–0·68) | 0·54% (0·47–0·61) | 162·97 (147·43–179·21) | 4·15% (3·75–4·56) | 3·77% (3·42–4·13) | 142·29 (128·45–157·36) | 3·62% (3·27–4·00) | 3·42% (3·10–3·78) |
≥50 years | 19·05 (16·22–21·82) | 1·92% (1·64–2·20) | 1·92% (1·63–2·20) | 116·98 (103·72–131·93) | 11·79% (10·46–13·30) | 11·78% (10·44–13·30) | 82·32 (70·52–93·83) | 8·30% (7·11–9·46) | 8·29% (7·10–9·45) |
Data are n (95% uncertainty interval) or % (95% uncertainty interval). Data taken from VLEG–GBD, 2020.1